[{"Assets_0_FY_USD":13432500000.0,"CommonStockSharesOutstanding_0_FY_shares":254479046.0,"EarningsPerShareBasic_4_FY_USD":9.09,"EarningsPerShareDiluted_4_FY_USD":9.01,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":2643500000.0,"NetIncomeLoss_4_FY_USD":2342100000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":7574400000.0,"StockholdersEquity_0_FY_USD":10100000000.0,"StockholdersEquityConverted_0_FY_USD":10100000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":259900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":257700000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20211231","fy":"2021.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20220209"}]